About MONA
MONA is a Belgian healthcare AI spin-off of KU Leuven and VITO, the Flemish Institute for Technological Research. We are led by a multidisciplinary team of experts in biomedicine, life sciences, artificial intelligence and health IT.
Our mission
Our mission is to reduce global blindness by transforming retinal screening. Not only for diabetes, but for any condition that threatens sight, such as diabetic retinopathy, age-related macular degeneration or glaucoma.
By making screening accessible, fast and affordable for both patients and healthcare systems, MONA supports better medical outcomes. By improving access to screening for vision-threatening conditions, MONA helps patients protect their vision.
Team
Prof. Ingeborg Stalmans
Medical Advisor
Globally recognised glaucoma and AI expert. Professor at KU Leuven, Head of the Glaucoma Unit at UZ Leuven and director of the ophthalmology research group.
Gaetan van Wijck
CEO
25 years in health tech, including J&J, Philips, Spectranetics and Melimpus.
Olivier Ménage
COO
PharmD with 25 years in international medical devices, including Abbott, Medtronic, Boston Scientific and J&J.
Stef Rommes
CTO
AI and machine-learning expert (MSc). Built and leads the MONA platform and its regulatory work.
Luc Vansteenkiste
President
Former CEO of Recticel and former chairman of the Federation of Enterprises in Belgium (VBO-FEB).